Hypertension in pregnancy: diagnosis and management
KEYWORDS: women, hypertension, pre-eclampsia, pregnancy, treatment, birth, committee, recommendations, antihypertensive, amended, risk, blood, evidence, care, gestational

follow up after hypertensive disorders of pregnancy. Full details of the evidence and the committee's discussion are in evidence review F: advice at discharge. 7 Haematological and biochemical monitoring in women with gestational hypertension What is the role of assessing haematological or biochemical parameters at diagnosis of gestational hypertension and during surveillance of gestational hypertension? [2010] Rationale and impact These sections briefly explain why the committee made the recommendations and how they might affect practice. They link to details of the evidence and a full description of the committee's discussion. Assessment of proteinuria Recommendations 1.2.1 to 1.2.7 Why the committee made the recommendations The committee were aware that there is often over-reliance on a proteinuria result in the diagnosis of pre-eclampsia, and agreed that healthcare professionals should use the results of a full clinical review, including severity of hypertension and other signs and symptoms, before making a diagnosis of pre-eclampsia. The committee amended the recommendation on automated dipstick tests from the 2010 guideline to emphasise that this should be used as a screening tool for proteinuria. The committee highlighted the importance of using automated dipstick analysis in secondary care rather than visual analysis, which they were aware from their experience
